Here are answers to readers’ queries on the performance of their stock holdings.
I have Bosch at ₹26,365 and Glenmark Pharma purchased at ₹756. Should I buy or hold?
R C Bhatia
Bosch (₹21,487.3): Ever since recording an all-time high at ₹27,989 in March 2015, the Bosch stock has been on an intermediate-term downtrend. Key resistance at ₹26,500 capped its rally in August and the stock resumed its downtrend with sharp declines.
However, the stock found support at around ₹16,000 this February and reversed higher. The subsequent rally was a strong one that breached a key resistance at ₹20,500 and retraced 50 per cent fibonacci retracement of the prior downtrend.
But the key resistance in the band between ₹22,000 and ₹22,500 limited this up-move recently and the stock is under selling pressure.
The near-term outlook for the stock is bearish. The stock can extend its decline and test its immediate support at ₹20,500.
Further declines can find support at ₹19,000, which is a key trend-deciding level. Any upward reversal from these supports can once again take the stock higher to ₹22,500. You can consider averaging the stock at lower levels with a stop-loss at the level of ₹18,500.
To alter the intermediate-term downtrend and strengthen the bullish momentum, the stock needs to emphatically breakthrough ₹22,500 level for an up-move to ₹23,600.
Next key medium-term resistances are pegged in the band between ₹26,000 and ₹26,500. However, a strong plunge below ₹19,000 can drag the stock down to ₹17,500 or even ₹16,000.
Glenmark Pharmaceuticals (₹774.1): The long-term uptrend in the stock of Glenmark Pharma continues to be intact. After retracing 50 per cent fibonacci retracement of this primary uptrend, the stock found support at ₹670 in February 2016 and resumed its uptrend.
But the resulting uptrend has failed to sustain the bullish momentum and encountered a resistance at ₹892 in late May. The stock has tumbled 11.5 per cent in the last couple of weeks, which has almost eroded your profit.
Currently, it tests a support at ₹760. A conclusive fall below this level can drag the stock down to ₹700 and then to ₹670 levels in the medium term. So, you can consider exiting the stock now and re-entering at lower levels with a long-term stop-loss at the level of ₹650.
A decisive break-out of the resistance zone between ₹890 and ₹900 will indicate resumption of the uptrend and take the stock higher to ₹1,000 and then to the ₹1,090-₹1,100 band in the long run.
On the downside, a strong plunge below the long-term support at ₹670 will mar the uptrend and drag the stock down to ₹600 or even to ₹550 levels.
I have bought Spicejet at ₹65. What is the future for the stock?
T V K Sankaran
Spicejet (₹63.7): In October 2015, the stock broke out of a vital resistance at ₹30 and began to accelerate.
The stock touched ₹95 this January and reversed trend, triggered by negative divergence in the weekly chart. After testing resistance at ₹85 in mid-May, it continued to decline. However, it now finds support at ₹60 and tests this level.
A slump below this level will strengthen the downtrend and drag the stock down to ₹50 in the medium term. Further declines can pull the stock down to ₹42 and then to ₹30 in the long term. But an upward reversal from its immediate support at ₹55 and ₹50 can take the stock higher to ₹70 and then to ₹85 levels.
You can make use of declines to accumulate with a stop-loss at ₹47. An emphatic breakthrough of ₹85 is needed to reinforce the bullishness and take the stock higher to ₹95.
Send your queries to techtrail@thehindu.co.in
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.